Initially developed for atopic dermatitis, Enveda's lead asset ENV-294 is now showing promise in treating asthma.

Oxidative stress plays a critical role in the pathogenesis of upper and lower respiratory tract diseases, such as chronic rhinosinusitis with nasal polyps (CRSwNP), allergic rhinitis (AR), and asthma ...

Akeso, Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the acceptance of its Investigational New Drug (IND) application by the China National Medical Products Administration (NMPA) ...

This syndrome is referred to as aspirin-induced asthma (AIA). The pathogenesis of AIA has implicated both the lipoxygenase (LO) and the cyclooxygenase (COX) pathways. By inhibiting the COX pathway ...

Recent findings suggest that post-COVID chronic cough may be driven by neurological factors, not just respiratory issues.

New classes of drug are based on a better understanding of the complex pathophysiology of asthma and include inhibitors of specific mediators, cytokines and chemokines. Several new classes of drug ...

The leading Severe Asthma Companies such as Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology ...

In conclusion, new information about the pathogenesis of asthma among athletes have appeared during the past few years, focusing upon the epithelial damage of the airways with airways inflammation and ...